Alignment Healthcare, Inc. (NASDAQ:ALHC) Receives $14.83 Consensus PT from Analysts

Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) have earned a consensus recommendation of “Moderate Buy” from the twelve research firms that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $14.83.

ALHC has been the topic of a number of research reports. Stephens restated an “overweight” rating and set a $17.00 price objective on shares of Alignment Healthcare in a research report on Monday, February 24th. Piper Sandler increased their target price on Alignment Healthcare from $14.00 to $21.00 and gave the stock an “overweight” rating in a report on Tuesday, March 4th. Bank of America increased their target price on Alignment Healthcare from $15.50 to $18.50 and gave the stock a “buy” rating in a report on Tuesday, March 4th. JPMorgan Chase & Co. upped their price target on Alignment Healthcare from $14.00 to $17.00 and gave the company a “neutral” rating in a research note on Thursday, March 6th. Finally, Stifel Nicolaus upped their price target on Alignment Healthcare from $16.00 to $18.00 and gave the company a “buy” rating in a research note on Friday, February 28th.

Insider Activity

In other Alignment Healthcare news, President Dawn Christine Maroney sold 30,000 shares of the stock in a transaction on Monday, March 17th. The stock was sold at an average price of $15.99, for a total transaction of $479,700.00. Following the sale, the president now owns 2,417,700 shares in the company, valued at $38,659,023. This represents a 1.23 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Andreas P. Wagner sold 14,878 shares of the stock in a transaction on Wednesday, February 12th. The stock was sold at an average price of $14.38, for a total value of $213,945.64. Following the completion of the sale, the insider now owns 200,885 shares in the company, valued at $2,888,726.30. This trade represents a 6.90 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 1,829,454 shares of company stock valued at $27,936,991 over the last three months. Corporate insiders own 6.60% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. R Squared Ltd bought a new stake in shares of Alignment Healthcare in the 4th quarter worth approximately $55,000. RiverPark Advisors LLC purchased a new stake in shares of Alignment Healthcare in the 4th quarter worth $106,000. Tower Research Capital LLC TRC increased its stake in shares of Alignment Healthcare by 146.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock worth $119,000 after purchasing an additional 6,286 shares in the last quarter. Ballentine Partners LLC purchased a new stake in Alignment Healthcare in the 4th quarter worth $121,000. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Alignment Healthcare in the 3rd quarter worth $131,000. 86.19% of the stock is owned by institutional investors.

Alignment Healthcare Stock Up 1.9 %

ALHC opened at $16.09 on Friday. The business has a 50 day moving average price of $14.48 and a 200 day moving average price of $12.51. Alignment Healthcare has a twelve month low of $4.46 and a twelve month high of $16.26. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. The firm has a market cap of $3.09 billion, a P/E ratio of -20.90 and a beta of 1.49.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.